Ghrelin Signaling

Overview

Ghrelin is a 28-amino-acid peptide hormone produced predominantly by oxyntic cells of the gastric fundus. It is the only known circulating orexigenic (appetite-stimulating) hormone and serves as the endogenous ligand for the growth hormone secretagogue receptor type 1a (GHS-R1a). Ghrelin signaling integrates hunger signaling, growth hormone release, energy metabolism, and reward-driven feeding behavior through a GPCR-mediated pathway that interfaces with hypothalamic feeding circuits, the pituitary growth hormone axis, and the mesolimbic dopamine system.

Understanding ghrelin signaling is particularly relevant to peptide research because the GHS-R1a receptor is the molecular target of growth hormone secretagogue peptides including GHRP-6, GHRP-2, hexarelin, and ipamorelin.

Ghrelin Structure and Processing

Acylation

A distinguishing feature of ghrelin is its post-translational octanoylation — the attachment of an eight-carbon fatty acid (octanoic acid) to the serine-3 residue by the enzyme ghrelin O-acyltransferase (GOAT). This acyl modification is essential for GHS-R1a binding and activation. Unacylated ghrelin (des-acyl ghrelin), which constitutes the majority of circulating ghrelin, does not activate GHS-R1a but may have independent biological activities through as-yet-unidentified receptors.

Secretion Pattern

Ghrelin levels follow a characteristic pattern:

• Preprandial rise — ghrelin concentrations increase before anticipated meal times, peaking just prior to eating
• Postprandial suppression — levels fall within 30-60 minutes of nutrient ingestion, particularly in response to carbohydrates and proteins
• Circadian variation — ghrelin exhibits nocturnal elevation with a peak in the early morning hours
• Chronic regulation — ghrelin is chronically elevated in caloric restriction and cachexia and suppressed in obesity (though obese individuals may retain sensitivity to its effects)

The GHS-R1a Receptor

Structure and Expression

GHS-R1a is a class A GPCR with seven transmembrane domains, expressed in:

• Hypothalamus — arcuate nucleus (ARC), ventromedial hypothalamus (VMH), and paraventricular nucleus (PVN)
• Pituitary — anterior pituitary somatotrophs
• Brainstem — nucleus tractus solitarius and area postrema
• Hippocampus — involved in memory and learning
• Ventral tegmental area (VTA) — dopaminergic reward circuitry
• Vagal afferent neurons — gastric and intestinal vagal nerve terminals
• Pancreatic islets — both alpha and beta cells
• Cardiovascular system — cardiomyocytes and vascular endothelium

Constitutive Activity

A notable property of GHS-R1a is its high constitutive activity — the receptor signals at approximately 50% of its maximal capacity even in the absence of ligand. This tonic signaling contributes to baseline appetite and growth hormone regulation. Inverse agonists that suppress this constitutive activity reduce food intake in preclinical models, suggesting that GHS-R1a basal signaling contributes meaningfully to energy homeostasis.

Signal Transduction

Ghrelin binding to GHS-R1a activates multiple intracellular cascades:

Gq/11 pathway (primary in appetite and GH release):

1. Activation of phospholipase C-beta (PLCbeta)
2. Generation of IP3 and DAG
3. IP3-mediated calcium release from endoplasmic reticulum stores
4. DAG-mediated protein kinase C (PKC) activation
5. In somatotrophs, intracellular calcium rise triggers growth hormone granule exocytosis

Gi/o pathway:

1. Inhibition of adenylyl cyclase in certain cell types
2. Activation of GIRK potassium channels
3. May modulate the firing rate of hypothalamic neurons

AMPK pathway:

1. Ghrelin activates AMPK in the hypothalamus via calcium/calmodulin-dependent protein kinase kinase 2 (CaMKK2)
2. Hypothalamic AMPK activation is a key orexigenic signal, promoting NPY/AgRP neuron firing
3. Conversely, ghrelin inhibits AMPK in peripheral tissues (liver, adipose), promoting lipogenesis

ERK1/2 pathway:

1. GHS-R1a activation stimulates the MAPK/ERK pathway
2. May contribute to cell survival and proliferative effects

Physiological Functions

Appetite Stimulation

Ghrelin is the most potent known orexigenic signal. Its appetite-stimulating effects are mediated through:

• NPY/AgRP neuron activation — ghrelin directly depolarizes NPY/AgRP-expressing neurons in the arcuate nucleus via GHS-R1a. These neurons release neuropeptide Y and agouti-related peptide, both powerful appetite stimulators.
• POMC neuron inhibition — ghrelin indirectly inhibits POMC/CART anorexigenic neurons, reducing satiety signaling
• Vagal afferent signaling — ghrelin acts on vagal afferents in the GI tract to relay hunger signals to the brainstem
• Reward enhancement — ghrelin signaling in the VTA increases dopamine release in the nucleus accumbens, promoting hedonic (pleasure-driven) eating

This appetite pathway is functionally opposed by GLP-1 receptor signaling and other anorexigenic hormones including leptin, PYY, and CCK.

Growth Hormone Release

Ghrelin stimulates GH release from anterior pituitary somatotrophs through a mechanism complementary to, but distinct from, growth hormone-releasing hormone (GHRH). While GHRH acts primarily through the Gs/cAMP/PKA pathway, ghrelin acts through the Gq/calcium/PKC pathway. The two signals synergize to produce robust GH pulses. This synergy is the pharmacological basis for combining GHS-R1a agonists with GHRH analogs in research protocols.

Ghrelin also amplifies GH secretion by:

• Antagonizing somatostatin-mediated GH suppression
• Directly stimulating hypothalamic GHRH neurons
• Coordinating with sleep-related GH release mechanisms

Energy Metabolism

Beyond acute appetite effects, ghrelin influences energy partitioning:

• Adipogenesis promotion — ghrelin shifts metabolism toward fat storage by promoting adipocyte differentiation and lipogenesis
• Glucose regulation — ghrelin increases hepatic glucose output and modulates insulin sensitivity
• Metabolic adaptation — elevated ghrelin during caloric restriction is thought to represent an adaptive mechanism to preserve energy stores and stimulate food-seeking behavior

Additional Functions

Ghrelin signaling also contributes to:

• Gastric motility — promotion of gastric acid secretion and GI motility (prokinetic effect)
• Cardioprotection — preclinical evidence of reduced cardiac remodeling and improved cardiac output
• Neuroprotection — hippocampal GHS-R1a activation enhances memory consolidation and synaptic plasticity
• Immune modulation — anti-inflammatory effects through suppression of pro-inflammatory cytokines

Pharmacological Relevance

Growth hormone secretagogue peptides interact with GHS-R1a at varying degrees of potency and selectivity:

Ipamorelin is notable for its selectivity — it stimulates GH release with minimal effects on appetite, cortisol, and prolactin, suggesting that GHS-R1a signaling can be partially dissociated between its GH-releasing and orexigenic functions.

Related Topics

• Ghrelin — the endogenous GHS-R1a ligand
• Growth Hormone Axis — the broader GH regulatory system
• GLP-1 Receptor Signaling — the opposing anorexigenic pathway
• AMPK Pathway — intracellular energy sensor activated by ghrelin
• Ipamorelin — a selective synthetic GHS-R1a agonist